In-Person Access Only | 4.50 Earn CME Credits

Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

The First Annual DEBATING LUNG Symposium will bring together nationally recognized thoracic oncology experts for a dynamic, evidence-based exploration of the most controversial and practice-changing topics in lung cancer care. Through a series of structured debates, faculty will present opposing perspectives on evolving standards of care, emerging therapeutics, biomarker-driven treatment strategies, multidisciplinary management, and future directions in thoracic oncology. Designed to challenge conventional thinking and encourage meaningful discussion, the symposium will provide attendees with balanced insights and practical approaches for integrating the latest clinical evidence into everyday practice.

Conference Agenda
Friday, February 12, 2027

Program Chairs:
TBD

3:00 - 4:00 PM
Arrival, Networking, and Registration
‍
4:00 - 5:30 PM
Breakout Focus Groups

5:30 - 6:30 PM
Networking Reception

7:00 - 9:00 PM
Faculty Dinner

Saturday, February 13, 2027

7:30 - 8:30 AM
Arrival, Breakfast, and Registration

8:30 - 8:45 AM
Welcome and Opening Remarks

8:45 - 10:15 AM
Lung Cancer Debate

10:15 - 10:30 AM
Breakfast & Exhibits

10:30 AM - 12:00 PM
Lung Cancer Debate

12:00 - 12:45 PM
Lunch & Exhibits

12:45 - 1:45 PM
Future Directions in Breast Debate

1:45 - 3:30 PM
Breakout Focus Groups

3:30 PM
ADJOURN

Agenda Subject To Change. All times are PST.

• Learning Objectives

• Accreditation Information | 7.50

  In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Nurses (ANCC) Credit Designation

  Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.

  Physicians (ACCME) Credit Designation

  Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Pharmacists and Pharmacy Technicians (ACPE) Credit Designation

  Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.

  NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.

  American Board of Internal Medicine (ABIM) MOC Credit

  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS.

• What to Expect | In-Person Learners

  • Complimentary registration for healthcare professionals

  • Expert debates addressing today's most controversial topics in lung cancer

  • Balanced, evidence-based perspectives from nationally recognized thoracic oncology leaders

  • Practical clinical insights to support real-world treatment decision-making

  • Interactive discussion and networking with faculty, peers, and industry partners

  • The latest advances in lung cancer research, precision medicine, and emerging therapeutic strategies